NewAmsterdam Pharma Company
NAMS
#4449
Rank
HK$14.38 B
Marketcap
HK$155.74
Share price
-15.50%
Change (1 day)
110.38%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of September 2024 : HK$3.29 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company has HK$3.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$2.65 B-32.17%
2022-12-31HK$3.92 B638.47%
2021-12-31HK$0.53 B475.79%
2020-12-31HK$92.19 M